Amphetamine Addiction: Signs, Withdrawal, and Treatment

Amphetamines are powerful central nervous system stimulants. Some are prescribed for medical conditions and can be used safely under professional supervision. When misused, however, they may create intense euphoria, bounding energy, absolute confidence, and hyper-alertness. For a brief time, fatigue seems to completely disappear, and thinking may feel unusually clear and sharp. Then the effect inevitably fades—and the overwhelming desire to feel it again may remain.

When Stimulation Becomes Dependence

Repeated misuse can rapidly lead to stimulant use disorder. A person may develop strong, persistent cravings, lose control over how often or how much they use, and continue their substance use despite visible damage to their health, career, or personal relationships. Some people mistakenly believe amphetamines are not truly addictive because stopping them may not cause the dramatic, visible physical symptoms associated with certain other drugs, such as alcohol or opioids. This is a dangerous and highly deceptive misconception.

Withdrawal Is Real

Amphetamine withdrawal—often clinically referred to as a "crash"—may include extreme physical fatigue, severe depression, acute anxiety, irritability, sleep disturbances, poor concentration, increased appetite, and intense psychological cravings. Severe depression during this vulnerable phase can sometimes involve intrusive thoughts of self-harm or suicide. The absence of obvious physical distress does not make the physiological and psychological dependence any less serious. Psychological symptoms can be incredibly overwhelming and may quickly pull a person back into active use just to escape the mental anguish.

When Paranoia Takes Over

Heavy, prolonged, or repeated use can cause profound psychological changes, including paranoia, severe hallucinations, or stimulant-induced psychosis. A person experiencing this state may genuinely believe they are being watched, followed, or actively threatened. They might hide, run away, confront others, or act aggressively because the perceived danger feels completely real to them. Severe agitation, auditory or visual hallucinations, chest pain, or any risk of harm to oneself or others requires immediate emergency medical care.

What Treatment May Involve

Treatment typically begins with a comprehensive medical and mental health assessment. Acute psychosis or serious physical complications may require inpatient hospital care and specific medications to stabilize cardiovascular or severe psychiatric symptoms.

After initial stabilization, behavioral treatments become the cornerstone of long-term recovery. Contingency management (a highly effective behavioral therapy that provides tangible rewards for positive behaviors), often combined with cognitive behavioral therapy (CBT), can significantly help reduce stimulant use and support lasting behavioral change. No medication is currently FDA-approved specifically for the treatment of stimulant use disorder, although clinicians may prescribe medications off-label to help manage withdrawal symptoms or to treat co-occurring mental health conditions.

With the patient’s consent, family involvement can substantially strengthen the support system and improve overall communication. Sustained recovery requires much more than mere willpower: it demands consistent professional care, the establishment of healthier daily routines, robust relapse-prevention skills, and supportive relationships that can turn the initial decision to stop using into a realistic, sustainable, and lifelong plan.

References

• National Institute on Drug Abuse. “Methamphetamine.” Updated November 20, 2024. Explains methamphetamine’s addictive potential, short-term stimulation, cravings, paranoia, psychosis, and other health risks. Online resource; no page numbers.
• Substance Abuse and Mental Health Services Administration. Treatment for Stimulant Use Disorders. TIP Series 33. SAMHSA Publication No. PEP21-02-01-004, updated 2021. Chapters 2–5 cover stimulant effects, medical and psychiatric complications, withdrawal, behavioral treatment, and continuing care.
• Clinical Guideline Committee. “The ASAM/AAAP Clinical Practice Guideline on the Management of Stimulant Use Disorder.” Journal of Addiction Medicine, 2024; 18(1S Suppl 1):1–56. Describes evidence-based care for stimulant intoxication, withdrawal, psychosis, and stimulant use disorder, including contingency management and appropriate emergency care.
• MedlinePlus. “Substance Use—Amphetamines.” Reviewed May 4, 2024. Provides accessible information about amphetamine effects, dependence, withdrawal symptoms, treatment, and the possible value of family support. Online resource; no page numbers.